ICIs, particularly the anti-programmed cell death protein (PD)-1/ligand (PD-L1) antibodies, can potentially reverse the immune-exhausted microenvironment of HCC and induce cytotoxic T cell-mediated destruction of HCC [11]. This evidence concerns the gene CD274 and hepatocellular carcinoma.